Simvastatin
Product Images NDC 53002-1527

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Simvastatin (NDC 53002-1527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021527)

Simvastatin 10 mg tablets packaging label, showing a bottle label for 100 tablets by RPK Pharmaceuticals, Inc. The label includes directions to take one tablet daily or as directed, the proprietary name, dosage strength, tablet count, and labeler information. It also has spaces for clinic name and barcode information on the label.*

FDA Label Image

Label Image (Lbl530021528)

Simvastatin 20 mg tablets packaging label from RPK Pharmaceuticals, Inc. The label indicates a prescription drug for oral administration with directions to take one tablet daily or as directed. It includes the product's NDC numbers, lot number, expiration date, barcode, and space for clinic information. The packaging contains 100 tablets.*

FDA Label Image

Label Image (Lbl530021569)

Simvastatin 40mg tablets packaging label from RPK Pharmaceuticals, Inc. The label instructs to take one tablet daily or as directed. The label includes the product name, strength, dosage form, and directions for use. It also shows a barcode, lot number, expiration date, and placeholder text for clinic and billing information.*

FDA Label Image

Simvastatin (Simvastatin Fig1)

A forest plot chart titled 'Major Vascular Events' and 'Major Coronary Events' depicting risk ratios with 95% confidence intervals for simvastatin tablets versus placebo among various patient subgroups. The groups include all patients, those with or without coronary heart disease (CHD), diabetes mellitus, peripheral vascular disease, cerebrovascular disease, gender, age ranges, and cholesterol levels (LDL and HDL). The chart compares incidence percentages and relative risk, showing favorability for simvastatin or placebo across subpopulations in a clinical study.*

FDA Label Image

Simvastatin (Simvastatin Str)

Chemical structure diagram of simvastatin, showing its molecular configuration with multiple cyclic rings, hydroxyl, methyl, and ester functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.